[Toxicity and efficacy of intermittent docetaxel chemotherapy for hormone refractory prostate cancer].

Olbert, P J; Weil, C; Hegele, A; Hofmann, R; Schrader, A J

[Toxicity and efficacy of intermittent docetaxel chemotherapy for hormone refractory prostate cancer]. / Toxizität und Effektivität wiederholter Docetaxel-therapie des hormonrefraktären Prostatakarzinoms.

Olbert, P J; Weil, C; Hegele, A; Hofmann, R; Schrader, A J.

Affiliation

Olbert PJ; Klinik für Urologie und Kinderurologie, Philipps-Universität Marburg, Baldingerstrasse, Marburg.

Aktuelle Urol ; 40(3): 164-8, 2009 May.

Article in De | MEDLINE | ID: mdl-19370533

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/toxicity; Bone Neoplasms/drug therapy; Bone Neoplasms/secondary; Prostatic Neoplasms/drug therapy; Taxoids/toxicity; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Biomarkers, Tumor/blood; Bone Neoplasms/blood; Bone Neoplasms/pathology; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Estramustine/administration & dosage; Estramustine/toxicity; Humans; Male; Middle Aged; Mitoxantrone/administration & dosage; Mitoxantrone/toxicity; Neoplasm Staging; Palliative Care; Prostate-Specific Antigen/blood; Prostatic Neoplasms/blood; Prostatic Neoplasms/mortality; Prostatic Neoplasms/pathology; Retreatment; Survival Rate; Taxoids/administration & dosage

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Prostatic Neoplasms / Bone Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Taxoids Type of study: Clinical_trials Limits: Adult / Aged / Humans / Male / Middle aged Language: De Journal: Aktuelle Urol Year: 2009 Document type: Article

Fulltext

XML

PubMed Links

Search on Google